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See OA 72-year-old woman with coronary artery bypass
graft surgery (CABG) with mitral valve replacement
(MVR) using a 27-mm Carpentier-Edwards bio-
prosthesis (Edwards Lifesciences, Irvine, California)
6 years earlier was referred to our institution with
severe, symptomatic prosthetic valve mitral stenosis.
Her clinical history was otherwise significant for
recent percutaneous coronary intervention, bilateral
renal artery stenting, and cerebrovascular disease with
a 90% stenosis of the left internal carotid artery (ICA)
and moderate stenosis of the right ICA. Prior
CABG/MVR was complicated by sternal wound
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Figure 1. Severe Prosthetic Mitral Valve Stenosis
(A) Transesophageal echocardiographic image demonstrating cont
mean gradients across the valve measured 32 and 18 mm Hg, resp
demonstrates restricted valve leaﬂet mobility with severe stenosis.Manuscript received January 3, 2012; accepted January 20, 2012.dehiscence necessitating complex reconstruction. In
preparation for surgery, stenting of the left ICA was
performed without complication. The patient was
then taken to the operative suite for MVR via a right
anterior thoracotomy; however, the surgery was
aborted because of profound adhesions with obliter-
ation of the pericardial space and patient intolerance
to single lung ventilation. Consequently, the patient
was brought to the cardiac catheterization laboratory
for transcatheter valve-in-valve (VIV) implantation in
the mitral position. Transesophageal echocardiogra-
phy confirmed severe prosthetic valve mitral stenosis
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Mitral Valve-In-Valve
e14(Fig. 1, Online Video 1). A 26-F Ascendra delivery system
Edwards Lifesciences) was placed in the left ventricular apex
nd then advanced to the left atrium (Fig. 2A). A 26-mm
dwards SAPIEN heart valve (Edwards Lifesciences) was
arefully positioned within the mitral prosthesis under
uoroscopic and echocardiographic guidance (Figs. 2B
nd 2C) and slowly deployed during rapid right ventric-
lar pacing and reduced pump flows. Only minimal
aravalvular regurgitation was noted at the end of the
rocedure, and there was no evidence of residual mitral
tenosis (Fig. 3, Online Video 2). Transcatheter VIV
mplantation within a failed mitral prosthetic valve has
een described as feasible and reproducible via the apical
pproach (1). Here, we present the first such case to our
nowledge performed in the United States in an elderly
Figure 2. Positioning of Transcatheter Heart Valve Across the Mitral Prost
(A) Fluoroscopic images in the right anterior oblique projection showing the 2
thetic mitral valve into the left atrium. (B) The transcatheter heart valve was th
Transesophageal echocardiography conﬁrmed appropriate transcatheter heart
Figure 3. VIV Implantation in the Mitral Position
(A) A 26-mm Edwards SAPIEN transcatheter heart valve is depicted within a m
well-expanded SAPIEN prosthesis, here in systole, with (C) mild, circumferentia
VIV  valve-in-valve. See Online Video 2.oman not amenable to redo surgical MVR.Reprint requests and correspondence: Dr. Igor F. Palacios,
Cardiology Division, Bigelow 800, Massachusetts General Hos-
pital, 55 Fruit Street, Boston, Massachusetts 02114. E-mail:
palacios.igor@mgh.harvard.edu.
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APPENDIX
scendra delivery system advanced via a transapical approach across the pros-
sheathed in the left atrium and pulled back into the mitral prosthesis. (C)
positioning.
rosthesis. (B) Transesophageal echocardiography demonstrated a
valvular regurgitation and mean transvalvular gradient  2 mm Hg.hesis
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